Tapewire

NYSE · USD

HUM

HUMANA INC

Export transactions ↓
Tapewire entity
1429
SEC CIK
0000049071
Parsed reports
738

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 15, 2023 Filed Dec 19, 2023 15:11 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 168 $463.58 $77,881.44
Disclosure

SEC source: 0001062993-23-022803 · form4.xml · nonDerivative · entry 6

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,770

F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 15:11 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 359 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022803 · form4.xml · nonDerivative · entry 5

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 15:11 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 169 $463.58 $78,345.02
Disclosure

SEC source: 0001062993-23-022803 · form4.xml · nonDerivative · entry 4

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,579

F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 15:11 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 362 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022803 · form4.xml · nonDerivative · entry 3

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,748

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 15:11 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 174 $463.58 $80,662.92
Disclosure

SEC source: 0001062993-23-022803 · form4.xml · nonDerivative · entry 2

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,386

F10 · shares: Disposition reported represents shares withheld for payment of tax liability associated with vesting of Restricted Stock Units on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 15:11 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 373 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022803 · form4.xml · nonDerivative · entry 1

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,560

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:57 UTC
Shetty Sanjay KPresident, CenterWell
Exercise / conversionRestricted Stock Units · Derivative 308 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022801 · form4.xml · derivative · entry 4

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 616

Underlying: Humana Common · 308 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 4/1/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 4/1/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:57 UTC
Shetty Sanjay KPresident, CenterWell
Tax withholdingHumana Common 139 $463.58 $64,437.62
Disclosure

SEC source: 0001062993-23-022801 · form4.xml · nonDerivative · entry 2

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169

F4 · shares: Shares disposed of represent payment for tax liability on Restricted Stock Units vesting on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:57 UTC
Shetty Sanjay KPresident, CenterWell
Exercise / conversionHumana Common 308 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022801 · form4.xml · nonDerivative · entry 1

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:56 UTC
Renaudin George IIPresident, Medicare & Medicaid
Exercise / conversionRestricted Stock Units · Derivative 359 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022799 · form4.xml · derivative · entry 13

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 719

Underlying: Humana Common · 359 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:56 UTC
Renaudin George IIPresident, Medicare & Medicaid
Exercise / conversionRestricted Stock Units · Derivative 229 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022799 · form4.xml · derivative · entry 11

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230

Underlying: Humana Common · 229 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

F6 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:56 UTC
Renaudin George IIPresident, Medicare & Medicaid
Exercise / conversionRestricted Stock Units · Derivative 241 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022799 · form4.xml · derivative · entry 9

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 241 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

F4 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:56 UTC
Renaudin George IIPresident, Medicare & Medicaid
Tax withholdingHumana Common 142 $463.58 $65,828.36
Disclosure

SEC source: 0001062993-23-022799 · form4.xml · nonDerivative · entry 6

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,547

F10 · shares: Shares disposed of represent payment for tax liability on Restricted Stock Units vesting on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:56 UTC
Renaudin George IIPresident, Medicare & Medicaid
Exercise / conversionHumana Common 359 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022799 · form4.xml · nonDerivative · entry 5

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,689

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:56 UTC
Renaudin George IIPresident, Medicare & Medicaid
Tax withholdingHumana Common 91 $463.58 $42,185.78
Disclosure

SEC source: 0001062993-23-022799 · form4.xml · nonDerivative · entry 4

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,330

F10 · shares: Shares disposed of represent payment for tax liability on Restricted Stock Units vesting on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:56 UTC
Renaudin George IIPresident, Medicare & Medicaid
Exercise / conversionHumana Common 229 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022799 · form4.xml · nonDerivative · entry 3

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,421

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:56 UTC
Renaudin George IIPresident, Medicare & Medicaid
Tax withholdingHumana Common 95 $463.58 $44,040.10
Disclosure

SEC source: 0001062993-23-022799 · form4.xml · nonDerivative · entry 2

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,192

F10 · shares: Shares disposed of represent payment for tax liability on Restricted Stock Units vesting on 12/15/23.

Read SEC document
December 15, 2023 Filed Dec 19, 2023 14:56 UTC
Renaudin George IIPresident, Medicare & Medicaid
Exercise / conversionHumana Common 241 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-022799 · form4.xml · nonDerivative · entry 1

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,287

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 06, 2023 Filed Nov 8, 2023 15:51 UTC
Huval Timothy S.Chief Administrative Officer
GiftHumana Common 600 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-020301 · form4.xml · nonDerivative · entry 1

Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,368

F10 · price: Shares disposed of represent a gift/charitable donation, effective November 6, 2023, in which no value was received in return.

Read SEC document
September 29, 2023 Filed Oct 3, 2023 14:42 UTC GrantRestricted Stock Units · Derivative 181 $490.94 $88,859.24
Disclosure

SEC source: 0001062993-23-018740 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,605

Underlying: Humana Common · 181 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
September 29, 2023 Filed Oct 3, 2023 14:39 UTC
SMITH BRAD DDirector
GrantRestricted Stock Units · Derivative 59 $490.94 $28,965.17
Disclosure

SEC source: 0001062993-23-018738 · form4.xml · derivative · entry 3

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191

Underlying: Humana Common · 59 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
September 29, 2023 Filed Oct 3, 2023 14:33 UTC GrantRestricted Stock Units · Derivative 33 $490.94 $16,200.86
Disclosure

SEC source: 0001062993-23-018736 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101

Underlying: Humana Common · 33 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
September 15, 2023 Filed Sep 19, 2023 13:39 UTC
SMITH BRAD DDirector
Exercise / conversionRestricted Stock Units · Derivative 386 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-018228 · form4.xml · derivative · entry 2

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 386 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_date: Initial award of $190,000 worth of restricted stock units pursuant to the annual Director Compensation Program. 100% of the award will vest on 9/15/2023 and forfeited in its entirety if service is less than one year.

F2 · derivative.expiration_date: Initial award of $190,000 worth of restricted stock units pursuant to the annual Director Compensation Program. 100% of the award will vest on 9/15/2023 and forfeited in its entirety if service is less than one year.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 13:39 UTC
SMITH BRAD DDirector
Exercise / conversionHumana Common 386 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-018228 · form4.xml · nonDerivative · entry 1

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 15:42 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 311 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-015742 · form4.xml · derivative · entry 9

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 311 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 08/1/2021, 33% of the award is vesting on 8/1/22, 8/1/23, and 8/1/24.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 15:42 UTC
Diamond Susan MChief Financial Officer
Tax withholdingHumana Common 145 $458.14 $66,429.58
Disclosure

SEC source: 0001062993-23-015742 · form4.xml · nonDerivative · entry 2

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,297

F12 · shares: Shares disposed of represent payment of tax liability resulting from vesting of restricted shares on 8/1/23.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 15:42 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 311 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-015742 · form4.xml · nonDerivative · entry 1

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,442

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 15:28 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionRestricted Stock Units · Derivative 210 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-015739 · form4.xml · derivative · entry 3

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 421

Underlying: Humana Common · 210 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25.

F2 · derivative.expiration_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 15:28 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Tax withholdingHumana Common 65 $458.14 $29,778.78
Disclosure

SEC source: 0001062993-23-015739 · form4.xml · nonDerivative · entry 2

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145

F4 · shares: Shares disposed of represent payment of tax liability resulting from vesting of restricted shares on 8/1/23.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 15:28 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionHumana Common 210 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-015739 · form4.xml · nonDerivative · entry 1

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 19:23 UTC GrantRestricted Stock Units · Derivative 37 $445.24 $16,473.70
Disclosure

SEC source: 0001062993-23-014425 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68

Underlying: Humana Common · 37 shares

Expires not disclosed

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
June 30, 2023 Filed Jul 5, 2023 17:01 UTC GrantRestricted Stock Units · Derivative 215 $445.24 $95,725.53
Disclosure

SEC source: 0001062993-23-014394 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,424

Underlying: Humana Common · 215 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
June 30, 2023 Filed Jul 5, 2023 16:54 UTC
SMITH BRAD DDirector
GrantRestricted Stock Units · Derivative 70 $445.24 $31,166.45
Disclosure

SEC source: 0001062993-23-014392 · form4.xml · derivative · entry 4

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132

Underlying: Humana Common · 70 shares

Expires not disclosed

F4 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F4 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F4 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
May 05, 2023 Filed May 8, 2023 18:04 UTC
Diamond Susan MChief Financial Officer
OtherHumana Common 700 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-010402 · form4.xml · nonDerivative · entry 7

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,131

F16 · shares: Reporting person transferred a total of 700 shares of direct ownership on May 5, 2023 pursuant to a Domestic Relations Order.

Read SEC document
May 04, 2023 Filed May 8, 2023 18:04 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionOptions · Derivative 1,508 $0.00 Strike: $376.61 $0.00
Disclosure

SEC source: 0001062993-23-010402 · form4.xml · derivative · entry 10

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,508

Underlying: Humana Common · 1,508 shares

Expires 2028-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

F3 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.

Read SEC document
May 04, 2023 Filed May 8, 2023 18:04 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionOptions · Derivative 1,861 $0.00 Strike: $350.79 $0.00
Disclosure

SEC source: 0001062993-23-010402 · form4.xml · derivative · entry 9

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 1,861 shares

Expires 2027-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

F2 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.

Read SEC document
May 04, 2023 Filed May 8, 2023 18:04 UTC
Diamond Susan MChief Financial Officer
GiftHumana Common 100 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-010402 · form4.xml · nonDerivative · entry 6

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,831

F15 · shares: Reporting person made a gift/charitable donation, effective May 4, 2023, in which no value was received in return.

Read SEC document
May 04, 2023 Filed May 8, 2023 18:04 UTC
Diamond Susan MChief Financial Officer
SaleHumana Common 1,500 $526.75 $790,118.85
Disclosure

SEC source: 0001062993-23-010402 · form4.xml · nonDerivative · entry 5

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,931

F14 · price: All shares sold at price reported.

Read SEC document
May 04, 2023 Filed May 8, 2023 18:04 UTC
Diamond Susan MChief Financial Officer
SaleHumana Common 2,656 $526.02 $1,397,107.53
Disclosure

SEC source: 0001062993-23-010402 · form4.xml · nonDerivative · entry 4

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,431

F13 · price: Price reported is weighted average sales price.

Read SEC document
May 04, 2023 Filed May 8, 2023 18:04 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 713 $350.79 $250,111.49
Disclosure

SEC source: 0001062993-23-010402 · form4.xml · nonDerivative · entry 3

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,087

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2023 Filed May 8, 2023 18:04 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 1,148 $350.79 $402,704.05
Disclosure

SEC source: 0001062993-23-010402 · form4.xml · nonDerivative · entry 2

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,374

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2023 Filed May 8, 2023 18:04 UTC
Diamond Susan MChief Financial Officer
Exercise / conversionHumana Common 1,508 $376.61 $567,927.88
Disclosure

SEC source: 0001062993-23-010402 · form4.xml · nonDerivative · entry 1

Diamond Susan M · CIK 0001782445 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,226

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 13:36 UTC
Shetty Sanjay KPresident, CenterWell
GrantRestricted Stock Units · Derivative 924 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-008389 · form4.xml · derivative · entry 3

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 924

Underlying: Humana Common · 924 shares

Expires not disclosed

F2 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_date: Restricted stock units granted to reporting person on 4/1/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F3 · derivative.expiration_date: Restricted stock units granted to reporting person on 4/1/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Read SEC document
April 01, 2023 Filed Apr 4, 2023 13:36 UTC
Shetty Sanjay KPresident, CenterWell
GrantOptions · Derivative 3,964 $0.00 Strike: $487.16 $0.00
Disclosure

SEC source: 0001062993-23-008389 · form4.xml · derivative · entry 2

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,964

Underlying: Humana Common · 3,964 shares

Expires 2030-04-01

F1 · security: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 4/1/2023, vesting in three annual increments from 4/1/24 to 4/1/26.

F1 · derivative.exercise_date: Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 4/1/2023, vesting in three annual increments from 4/1/24 to 4/1/26.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 17:02 UTC
SMITH BRAD DDirector
GrantRestricted Stock Units · Derivative 62 $487.16 $30,203.93
Disclosure

SEC source: 0001062993-23-008403 · form4.xml · derivative · entry 4

SMITH BRAD D · CIK 0001284323 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62

Underlying: Humana Common · 62 shares

Expires not disclosed

F4 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F4 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F4 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
March 31, 2023 Filed Apr 4, 2023 17:01 UTC GrantRestricted Stock Units · Derivative 194 $487.16 $94,509.08
Disclosure

SEC source: 0001062993-23-008401 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,209

Underlying: Humana Common · 194 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
March 31, 2023 Filed Apr 4, 2023 15:35 UTC GrantRestricted Stock Units · Derivative 31 $487.16 $15,101.97
Disclosure

SEC source: 0001062993-23-008393 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31

Underlying: Humana Common · 31 shares

Expires not disclosed

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
March 21, 2023 Filed Mar 23, 2023 14:27 UTC
Renaudin George IIPresident, Medicare & Medicaid
OtherPhantom Stock Units · Derivative 3 $500.87 $1,502.61
Disclosure

SEC source: 0001062993-23-007505 · form4.xml · derivative · entry 9

Renaudin George II · CIK 0001964078 · President, Medicare & Medicaid

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 151

Underlying: Humana Common · 3 shares

Expires not disclosed

F9 · security: Phantom Stock Units held for the benefit of reporting person as of March 21, 2023 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F9 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 21, 2023 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F9 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2023 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F9 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 21, 2023 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F9 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 21, 2023 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 15:18 UTC Exercise / conversionRestricted Stock Units · Derivative 441 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-005726 · form4.xml · derivative · entry 2

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 441 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_date: Initial award of $190,000 worth of restricted stock units pursuant to the annual Director Compensation Program. 100% of the award will vest on 3/1/2023 and forfeited in its entirety if service is less than one year.

F2 · derivative.expiration_date: Initial award of $190,000 worth of restricted stock units pursuant to the annual Director Compensation Program. 100% of the award will vest on 3/1/2023 and forfeited in its entirety if service is less than one year.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 15:18 UTC Exercise / conversionHumana Common 441 $0.00 $0.00
Disclosure

SEC source: 0001062993-23-005726 · form4.xml · nonDerivative · entry 1

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 441

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.